In vitro antimalarial activity of a new organometallic analog, ferrocene-chloroquine

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 3, 1998, Pages 540-544

  Domarle, O ^a   Blampain, G ^a   Agnaniet, H ^b   Nzadiyabi, T ^a   Lebibi, J ^b   Brocard, J ^c   Maciejewski, L ^c   Biot, C ^c   Georges, A J ^a   Millet, P ^a  

^a CENTRE INTERNATIONAL DE RECHERCHES MÉDICALES DE FRANCEVILLE   (Gabon)

^b Univ des sci tech de Masuku   (Gabon)

^c UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; FERROCENE DERIVATIVE; ORGANOMETALLIC COMPOUND;

ANTIMALARIAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; DRUG STRUCTURE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0031938083     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.3.540     Document Type: Article

References (43)

1. Basco, L. K., C. Ruggeri, and J. Le Bras. 1994. Molécules antipaludiques. Masson, Paris, France.
2. Biot, C., G. Glorian, L. A. Maciejewski, O. Domarle, P. Millet, H. Abessolo, D. Dive, A. J. G. Georges, H. Abessolo, D. Dive, J. Lebibi, and J. S. Brocard. 1997. Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue. J. Med. Chem. 40:3715-3718.
3. Bray, P. G., R. E. Howells, G. Y. Ritchie, and S. A. Ward. 1992. Rapid chloroquine efflux phenotype in both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. A correlation of chloroquine sensitivity with energy-dependent drug accumulation. Biochem. Pharmacol 44:1317-1324.
4. Brocard, J., J. Lebibi, and L. A. Maciejewski. 1995. Brevet d'invention no. 9505532 du 10/05/95; Brevet international no. PCT/FR96/00721 du 10/05/96.
5. Chizzolini, C., A. Dupont, J. P. Akue, M. H. Kauffman, A. S. Verdini, A. Pessi, and G. Del Giudice. 1988. Natural antibodies against three distinct and denned antigens of Plasmodium falciparum in residents of a mesoendemic area in Gabon. Am. J. Trop. Med. Hyg. 39:150-156.
6. Chou, A. C., R. Chevli, and C. D. Fitch. 1980. Ferriprotoporphyrin IX fulfills the criteria for identification as the chloroquine receptor of malaria parasites. Biochemistry 19:1543-1549.
7. De, D., F. M. Krogstad, F. B. Cogswell, and D. J. Krogstad. 1996. Aminoquinolines that circumvent resistance in Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg. 55:579-583.
8. De Duve, C., T. De Barsy, B. Poole, A. Trouet, P. Tulkens, and F. Van Hoof. 1974. Lysosomotropic agents. Biochem. Pharmacol. 23:2495-2531.
9. Desjardins, R. E., C. J. Canfield, J. D. Haynes, and J. D. Chulay. 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16:710-718.
10. Domarle, O., F. Ntoumi, D. Belleoud, A. Sall, A. J. Georges, and P. Millet. 1997. Plasmodium falciparum: adaptation in vitro of isolates from symptomatic individuals in Gabon: polymerase chain reaction typing and evaluation of chloroquine susceptibility. Trans. R. Soc. Trop. Med. Hyg. 91:208-209.
11. Ferrari, V., and D. J. Cutler. 1991. Simulation of kinetic data on the influx and efflux of chloroquine by erythrocytes infected with Plasmodium falciparum. Evidence for drug-importer in chloroquine-sensitive strains. Biochem. Pharmacol. 42(Suppl.):S167-S179.
12. Fitch, C. D. 1986. Antimalarial schizonticides: ferriprotoporphyrin IX interaction hypothesis. Parasitol. Today 2:330-331.
13. 14C-chloroquine. Antimicrob. Agents Chemother. 3:545-548.
14. Fitch, C. D. 1970. Plasmodium falciparum in owl monkeys: drug resistance and chloroquine binding capacity. Science 169:289-290.
15. Gabay, T., and H. Ginsburg. 1993. Hemoglobin denaturation and iron release in acidified red blood cell lysates - a possible source of iron for intraerythrocytic malaria parasites. Exp. Parasitol. 77:261-272.
16. Gabay, T., M. Krugliak, G. Shalmiev, and H. Ginsburg. 1994. Inhibition by anti-malarial drugs of haemoglobin denaturation and iron release in acidified red blood cell lysates - a possible mechanism of their anti-malarial effect? Parasitology 108:371-381.
17. Ginsburg, H. 1990. Antimalarial drugs: is the lysosomotropic hypothesis still valid? Parasitol. Today 6:334-337.
18. Ginsburg, H., and R. A. Demel. 1983. The effect of ferriprotoporphyrin IX and chloroquine on phospholipid monolayers and the possible implication to antimalarial activity. Biochim. Biophys. Acta 732:316-319.
19. Gordeuk, V. R., P. E. Thuma, G. M. Brittenham, G. Biemba, S. Zulu, G. Simwanza, P. Kalense, A. M'Hango, D. Parry, A. A. Poltera, and M. Aikawa. 1993. Iron chelator as a chemotherapeutic strategy for falciparum malaria. Am. J. Trop. Med. Hyg. 48:193-197.
20. Haldar, K., C. L. Henderson, and G. A. M. Cross. 1986. Identification of the parasite transferrin receptor of Plasmodium falciparum-infected erythrocytes and its acylation via 1,2-diacyl-sn-glycerol. Proc. Natl. Acad. Sci. USA 83: 8565-8569.
21. Hershko, C., and T. E. A. Peto. 1988. Deferoxamine inhibition of malaria is independent of the host iron status. J. Exp. Med. 168:375-387.
22. Krogstad, D. J., I. Y. Gluzman, B. L. Herwaldt, P. H. Schlesinger, and T. E. Wellems. 1992. Energy dependence of chloroquine and chloroquine efflux in Plasmodium falciparum. Biochem. Pharmacol. 43:57-62.
23. Krogstad, D. J., I. Y. Gluzman, D. E. Kyle, A. M. Oduola, S. K. Martin, W. K. Milhous, and P. H. Schlesinger. 1987. Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance Science 238:1283-1285.
24. Le Bras, J., and P. Deloron. 1983. In vitro study of drug sensitivity of Plasmodium falciparum: evaluation of a new semi-micro test. Am. J. Trop. Med. Hyg. 32:447-451.
25. Leung, H. W., D. W. Hallesy, L. D. Shott, F. J. Murray, and D. J. Paustenbach. 1987. Toxicological evaluation of substituted dicyclopentadienyliron (ferrocene) compounds. Toxicol. Lett. 38:103-108.
26. Martin, S. K., A. M. J. Oduola, and W. K. Milhous. 1987. Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science 235: 899-901.
27. Murray, M. J., A. B. Murray, N. J. Murray, and M. B. Murray. 1975. Refeeding-malaria and hyperferraemia. Lancet ii:653-654.
28. Nielsen, P., and H. C. Heinrich. 1993. Metabolism of iron from (3,5,5-trimethylhexanoyl) ferrocene in rats. A dietary model for severe iron overload. Biochem. Pharmacol. 45:385-391.
29. Oppenheimer, S. J. 1989. Iron and malaria. Parasitol. Today 5:77-79.
30. Peto, T. E. A., and J. L. Thompson. 1986. A reappraisal of the effects of iron and desferrioxamine on the growth of Plasmodium falciparum in vitro: the unimportance of serum iron. Br. J. Haemotol. 63:273-280.
31. Pollack, S. 1989. Plasmodium falciparum iron metabolism. Prog. Clin. Biol. Res. 313:151-161.
32. Ridley, R. G., W. Hofheinz, H. Matile, C. Jaquet, A. Dorn, R. Masciadri, S. Jolidon, W. F. Richter, A. Guenzi, M. A. Girometta, H. Urwyler, W. Huber, S. Thaithong, and W. Peters. 1996. 4-Aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum. Antimicrob. Agents Chemother. 40:1846-1854.
33. Rodriguez, M. H., and M. Jungery. 1986. A protein on Plasmodium falciparum-infected erythrocytes functions as a transferrin receptor. Nature 324: 388-391.
34. Sanchez-Lopez, R., and K. Haldar. 1992. A transferrin-independent iron uptake activity in Plasmodium falciparum-infected and uninfected erythrocytes. Mol. Biochem. Parasitol. 55:9-20.
35. Schuster, B. G., and W. K. Milhous. 1993. Reduced resources applied to antimalarial drug development. Parasitol. Today 9:167-168.
36. Slater, A. F. 1993. Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum. Pharmacol. Ther. 57:203-235.
37. Stevens, A. R., Jr. 1954. Iron in clinical medicine. University of California Press, Berkeley.
38. Trager, W., and J. B. Jensen. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
39. Vander Jagt, D. L., L. A. Hunsaker, and N. M. Campos. 1986. Characterization of a hemologin-degrading, low molecular weight protease from Plasmodium falciparum. Mol. Biochem. Parasitol. 18:389-400.
40. van Hensbroek, M. B., S. Morris Jones, S. Meisner, S. Jaffar, L. Bayo, R. Dackour, C. Phillips, and B. M. Greenwood. 1995. Iron, but not folic acid, combined with effective antimalarial therapy promotes haematological recovery in African children after acute falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 89:672-676.
41. Verdier, F., J. Le Bras, F. Clavier, I. Hatin, and M. C. Blayo. 1985. Chloroquine uptake by Plasmodium falciparum-infected human erythrocytes during in vitro culture and its relationship to chloroquine resistance. Antimicrob. Agents Chemother. 27:561-564.
42. Warhurst, D. C. 1988. Mechanism of chloroquine resistance malaria Parasitol. Today 4:211-213.
43. Yeary, R. A. 1969. Chronic toxicity of dicyclopentadienyl iron (ferrocene) in dogs. Toxicol. Appl. Pharmacol. 15:666-676.